SCHW
52
3
HES
67
5
MDT
42
-2
CPB
44
4
INTC
41
-6
BEN
48
4
TGT
45
3
CF
42
6
BWA
41
3
RF
47
4
HCA
57
2
PYPL
37
-4
JBHT
42
4
YUM
52
9
CVX
25
3
APD
40
-15
TSN
38
3
GE
65
-5
PLD
64
3
SE
44
-13
SCHW
52
3
HES
67
5
MDT
42
-2
CPB
44
4
INTC
41
-6
BEN
48
4
TGT
45
3
CF
42
6
BWA
41
3
RF
47
4
HCA
57
2
PYPL
37
-4
JBHT
42
4
YUM
52
9
CVX
25
3
APD
40
-15
TSN
38
3
GE
65
-5
PLD
64
3
SE
44
-13
Financhill
Back

Allstate Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
45

ALL
Allstate

Last Price:
161.32
Seasonality Move:
2.09%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
45
Allstate (ALL) is a Sell

Is Allstate a Buy, Sell or Hold?

  • The current Allstate [ALL] share price is $161.34. The Score for ALL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ALL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALL Stock Price Chart

What is Allstate's stock price today?

  • The Allstate share price today is $161.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALL is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

ALL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 45.34 Sell
Chaikin Money Flow: -365733 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (160.52 - 165.9) Sell
Bollinger Bands (100): (159.27 - 169.87) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

ALL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 160.44 Buy
20-day SMA: 162.46 Sell
50-day SMA: 166.52 Sell
200-day SMA: 148.29 Buy
8-day EMA: 161.27 Buy
20-day EMA: 162.55 Sell
50-day EMA: 164.26 Sell
200-day EMA: 151.6 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Allstate Earnings Growth & ALL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.51 per share, a decrease next quarter of $0.22 per share, an increase this year of $14.34 per share, and an increase next year of $4.17 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Allstate Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):